These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8976125)

  • 1. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
    Tsukamoto K; Emi M; Nakamura Y
    Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic alterations and DNA-based diagnosis in breast cancer].
    Matsumoto S; Emi M; Kasumi F; Nakamura Y
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):375-80. PubMed ID: 8709940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular analysis of breast cancers: recent developments].
    Bièche I; Lidereau R
    Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in breast cancer.
    Bièche I; Lidereau R
    Genes Chromosomes Cancer; 1995 Dec; 14(4):227-51. PubMed ID: 8605112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer of the breast. Genetic alterations and prognostic factors].
    Bièche I; Champème MH; Lidereau R
    Pathol Biol (Paris); 1990 Sep; 38(7):727-34. PubMed ID: 2235089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of gene diagnosis in breast cancer].
    Iwase H
    Rinsho Byori; 1998 Sep; 46(9):869-75. PubMed ID: 9800471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
    Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
    Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
    Bièche I; Champème MH; Lidereau R
    Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
    Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE
    Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity in familial breast carcinomas.
    Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
    Cancer Res; 1993 Sep; 53(18):4356-61. PubMed ID: 8364930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas.
    Yokota J; Ookawa K; Nishikawa R; Sameshima Y
    Princess Takamatsu Symp; 1991; 22():71-6. PubMed ID: 1844253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
    Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
    Lau SH; Guan XY
    Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor genes in breast cancer: an overview.
    Steeg PS
    Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.